A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
via Google News
The Latest on: TB vaccine
- Bill Gates: ‘Vaccines are a miracle. It’s mind-blowing somebody could say the opposite’on May 15, 2022 at 3:01 am
So it’s a huge area, and I think we’re on the verge of some breakthroughs there. I also wish we had an HIV vaccine, a TB vaccine, but I’ll still put the solution to malnutrition at the top of my wish ...
- This vaccine could save thousands of lives but we only see it in 2030on May 13, 2022 at 11:42 pm
In 2019, the World Health Organisation (WHO) hailed the results of a candidate (TB) vaccine as a major scientific breakthrough. But years later we are not much closer ...
- CCMB's mRNA COVID vaccine more effective against variantson May 13, 2022 at 3:51 pm
Since India lacked mRNA vaccine technology, CSIR-Centre for Cellular and Molecular Biology (CCMB) has indigenously developed a better version of the mRNA vaccine.
- This vaccine could save tens of thousands of South African lives each year, but we’ll only see it in 2030on May 13, 2022 at 3:37 pm
In South Africa alone, such a vaccine would save tens of thousands of lives each year, and save billions of rands in direct and indirect costs from the disease. Between 2016 and 2 ...
- Worldwide BCG Tuberculosis (TB) Vaccine Industry to 2027 - by Type, End-user and Region - ResearchAndMarkets.comon May 12, 2022 at 3:30 am
The "Global BCG Tuberculosis (TB) Vaccine Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global BCG vaccine market is anticipated to grow at a considerable CAGR ...
- Start talking about mRNA vaccine access now, say expertson May 11, 2022 at 9:28 am
While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world's most neglected infectious diseases say that conversations about ...
- The lifesaving TB vaccine South Africans will only see in 2030on May 10, 2022 at 5:49 am
The M72 TB vaccine could save tens of thousands of South African lives each year, but will only be available in 2030.
- South Africa: This Vaccine Could Save Tens of Thousands of South African Lives Each Year, but We'll Only See It in 2030on May 9, 2022 at 6:42 am
In 2019, the World Health Organisation (WHO) hailed the results of a candidate tuberculosis (TB) vaccine as a major scientific breakthrough. But years later we are not much closer to seeing the ...
- CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccineon May 5, 2022 at 6:40 am
Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis in ≥6 years of age, the Subject Expert Committee (SEC) of the ...
- Evaluation of the potential of new and repurposed TB vaccineson May 5, 2022 at 4:37 am
In 2019, around 10 million TB cases were reported, many of which were identified to be resistant to multiple drugs. . Image Credit: Kateryna Kon/Shutterstock To date, only one TB vaccine is available, ...
via Bing News